apceth expands gene, cell therapy manufacturing business

By Zachary Brennan

- Last updated on GMT

apceth expands gene, cell therapy manufacturing business

Related tags Dna Stem cell

German-based contract manufacturer apceth has received regulatory approval to use two new GMP cleanrooms for aseptic processing, which will be used for the handling and genetic manipulation of various types of cell and gene therapies. 

The expansion will now see the company with manufacturing capacity of 600 m2​. The GMP inspection was conducted by the Bavarian State Authorities and the German regulatory agency Paul-Ehrlich-Institute (PEI).

The subject of the inspection was two products, which are now included in Apceth's GMP manufacturing license. The first is Agenmestencel-L​, apceth's allogeneic genetically modified mesenchymal stem cells (gmMSCs) for solid cancer. The second product is a genetically modified ATMP (advanced-therapy medicinal product) that Apceth is manufacturing at clinical GMP grade for an unnamed client.

The expansion will ensure that we remain one step ahead of the manufacturing capacity demands of our current and new clients, as well as for our own therapeutic pipeline​,” said Ulrike Verzetnitsch, Apceth CTO and former Director of Production at Baxter and Takeda.

Related news

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Content provided by Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Enhance your cGMP chemical supply chain

Enhance your cGMP chemical supply chain

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 09-Feb-2023 | White Paper

Supply chain issues have real, quantifiable impacts on biomanufacturers. However, the right support can make a cGMP supply chain operate seamlessly. Thermo...

Related suppliers

Follow us

Products

View more

Webinars